Medical Digest & Congress Report

Lymphoma and CLL highlights of the ASH 2025

09 Jan 2026

Contributed by Lukas

Catherine S. Diefenbach discusses the lymphoma and CLL highlights at the American Society of Hematology's 67th Annual Meeting.Video: https://medic...

Quadruplet Therapy in Multiple Myeloma - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Rahul Banerjee discusses the quadruplet therapy in multiple myeloma at the American Society of Hematology's 67th Annual Meeting.Video: https://med...

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Jennifer Woyach discusses the noncovalent BTK inhibitor pirtobrutinib achieved noninferiority to the covalent BTK inhibitor ibrutinib in terms of over...

Primary efficacy analysis of TKI and inotuzumab ozogamicin-based therapy for newly diagnosed Ph+ ALL - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Anand A. Patel discusses the primary efficacy analysis of a Phase II study investigating tyrosine kinase inhibitor and inotuzumab ozogamicin-based the...

Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Jesse Tettero discusses the results from the HARMONY Alliance study at the American Society of Hematology's 67th Annual Meeting.Video:

Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial

07 Jan 2026

Contributed by Lukas

Jennifer R. Brown explains the results from the ALPINE trial at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldig...

Azacitidine–Venetoclax Combination Outperforms Standard Care in Acute Myeloid Leukemia Patients Eligible for Intensive Chemotherapy - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Amir Fathi discusses the results from a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemother...

What's new in myeloma? - report from ASH 2025

07 Jan 2026

Contributed by Lukas

Enrique Ocio discusses what's new in multiple myeloma treatement at the American Society of Hematology's 67th Annual Meeting.Video: https://me...

Novelties in Acute Myeloid Leukemia at ASH2025

07 Jan 2026

Contributed by Lukas

Mark Levis discusses the novelties in acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldig...

State of the art treatment of Chronic Myeloid Leukemia - report from ASH 2025

18 Dec 2025

Contributed by Lukas

Michael J. Mauro discusses the state of the art treatment of chronic myeloid leukemia at the American Society of Hematology's 67th Annual Meeting....

Myelodysplastic Syndrome Highlights from ASH 2025

18 Dec 2025

Contributed by Lukas

Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meetin...

COBRA trial and other novelties in multiple myeloma at ASH 2025

18 Dec 2025

Contributed by Lukas

Andrzej Jakubowiak discusses the COBRA trial and other novelties in multiple myeloma at the American Society of Hematology's 67th Annual Meeting.V...

Multiple Myeloma Highlights from ASH 2025

18 Dec 2025

Contributed by Lukas

Paul G Richardson discusses multiple myeloma highlights at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldigest.o...

Diagnosis and Management of Cold Agglutinin Disease - report from ASH 2025

18 Dec 2025

Contributed by Lukas

Sigbjorn Berentsen discusses the diagnosis and management of cold agglutinin disease at the American Society of Hematology's 67th Annual Meeting.V...

Breakthrough in the treatement of Multiple Myeloma - report from ASH 2025

18 Dec 2025

Contributed by Lukas

Xavier Leleu explains the breakthrough in the treatement of multiple myeloma at the American Society of Hematology's 67th Annual Meeting.Video: ht...

Novelties in Diffuse Large B-cell Lymphoma at ASH2025

18 Dec 2025

Contributed by Lukas

Joshua Brody discusses the novelties in diffuse large B-cell lymphoma at the American Society of Hematology's 67th Annual Meeting.Video: https://m...

First-of-Its-Kind Phase 3 Trial Shows Pirtobrutinib Is Noninferior to Ibrutinib in Treatment-Naïve CLL - report from ASH 2025

17 Dec 2025

Contributed by Lukas

Wojciech Jurczak discusses the results from the global, randomized BRUIN CLL-313 study presented at the American Society of Hematology's 67th Annu...

New findings support a chemo-free approach for treating Ph+ ALL - report from ASH 2025

17 Dec 2025

Contributed by Lukas

Sabina Chiaretti discusses the results of the phase 3 GIMEMA ALL2820 study at the American Society of Hematology's 67th Annual Meeting.Video: http...

Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia - report from ASH 2025

17 Dec 2025

Contributed by Lukas

Hanny Al-Samkari discusses the results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltro...

Bispecific Combo May Offer “Functional Cure” in Multiple Myeloma - report from ASH 2025

17 Dec 2025

Contributed by Lukas

María-Victoria Mateos discusses the results of a phase 3 study of teclistamab plus daratumumab for relapsed refractory multiple myeloma presented at ...

Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma - report from ASH 2025

17 Dec 2025

Contributed by Lukas

Lorenzo Falchi discusses the results of phase 3 EPCORE FL-1 trial presented at the American Society of Hematology's 67th Annual Meeting.Video: htt...

Novelties in Follicular Lymphoma at ASH2025

17 Dec 2025

Contributed by Lukas

Joshua Brody discusses the novelties in follicular lymphoma at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldige...

Remote BP Monitoring and Drug Titration – Does it work? How do we do it? - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor Beverly B. Green shares her insights on remote BP monitoring and drug titrationat after the AHA Scientific Sessions 2025.Video: https://medi...

Effectiveness of High-Dose vs. Standard-Dose Inactivated Influenza Vaccine in Individuals with and without Atherosclerotic Cardiovascular Disease: A Pooled FLUNITY-HD Trial Analysis

03 Dec 2025

Contributed by Lukas

Professor Manan Pareek shares his insights on the results from the FLUNITY-HD trial analysis at AHA Scientific Sessions 2025.Video: https://medicaldig...

Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor Siddharth M. Patel shares his insights on the results from the DAPA ACT HF-TIMI 68 trial at AHA Scientific Sessions 2025.Video: https://medi...

DASH-Patterned Groceries Reduce Blood Pressure - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor Stephen P. Juraschek discusses the results from the GoFresh randomized clinical trial presented at at AHA Scientific Sessions 2025.Video: ht...

TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor Sripal Bangalore discusses the findings from the TUXEDO-2 trial presented at at AHA Scientific Sessions 2025.Video: https://medicaldigest.or...

Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor John M. Flack shares his insights on the new paradigms and novel therapies in aldosterone and mineralocorticoid receptors at AHA Scientific ...

Navigating AHA Scientific Statements: Advancing Evidence-Based Cardiovascular Care - report from AHA 2025

03 Dec 2025

Contributed by Lukas

Professor Bradley S. Marino shares his insights on the advancing evidence-based cardiovascular care at AHA Scientific Sessions 2025.Video: https://med...

A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025

02 Dec 2025

Contributed by Lukas

Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025....

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides - report from AHA 2025

02 Dec 2025

Contributed by Lukas

Professor Stephen Nicholls shares his insights on the first-in-human trial of CRISPR gene-editing therapy at AHA Scientific Sessions 2025.Video: https...

Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure - report from AHA 2025

02 Dec 2025

Contributed by Lukas

Professor Stephen Nicholls shares his insights on the pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial at AHA Scientific Sessions ...

Impact of Cardiovascular-Focused Messaging to Improve Influenza Vaccination on Cardiovascular-Kidney-Metabolic Care Patterns and Clinical Outcomes: Insights from the KP VACCINATE Megatrial

02 Dec 2025

Contributed by Lukas

Professor Ankeet Bhatt shares his insights from the KP VACCINATE Megatrial presented at at AHA Scientific Sessions 2025.Videó: https://medicaldigest....

Resistance Exercise Therapy After COVID-19 Infection: a Randomized, Controlled Trial - report from AHA 2025

02 Dec 2025

Contributed by Lukas

Professor Stuart Gray shares his insights on the resistance exercise therapy after COVID-19 infection at AHA Scientific Sessions 2025.Video: https://m...

Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation - report from AHA 2025

02 Dec 2025

Contributed by Lukas

Professor Amrish Deshmukh shares his insights on metformin as an adjunctive therapy to catheter ablation of atrial fibrillation at AHA Scientific Sess...

Highlights of AHA / ACC Blood Pressure Management Guideline

02 Dec 2025

Contributed by Lukas

Professor Daniel Jones shares his insights on the AHA / ACC Blood Pressure Management Guideline at AHA Scientific Sessions 2025.Video: https://medical...

POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With HFrEF - report from AHA 2025

01 Dec 2025

Contributed by Lukas

Professor Ambarish Pandey presented the data of POLY-HF trial at AHA Scientific Sessions 2025.Video: https://medicaldigest.org/scientific-contents/int...

SOTA-P-CARDIA Trial: A Randomized Trial of Sotagliflozin in HFpEF patients without diabetes - report from AHA 2025

01 Dec 2025

Contributed by Lukas

Professor Juan J. Badimon discusses the SOTA-P-CARDIA Trial, a randomized trial of sotagliflozin in HFpEF patients without diabetes, presented at AHA ...

The Clinicians view on the 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025

01 Dec 2025

Contributed by Lukas

Professor Matthew Tomey discusses the clinicians view on the2025 Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025.Video: https:/...

The New 2025 Guideline for Acute Coronary Syndromes: The European perspective - report from AHA 2025

01 Dec 2025

Contributed by Lukas

Professor Tiziana Claudia Aranzulla shares her insights on the Guideline for Acute Coronary Syndromes from the European perspective at AHA Scientific ...

State of the art tumor-targeting IL-12 immunocytokine therapies - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Dr. Gregory Conn shares his insights on state of the art tumor-targeting IL-12 immunocytokine therapies after SITC's 40th Anniversary Annual Meeti...

Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th...

Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Me...

Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal ade...

How to optimize PD1/PDL1 treatment? - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting.Video: https://med...

Modulating the Tumor Microenvironment with T Cell Bispecifics - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual ...

Comparative Cardioprotective Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors in Pulmonary Arterial Hypertension: Insights from a Large-Scale Real-World data analysis

27 Nov 2025

Contributed by Lukas

Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonar...

Ensifentrine treatment improves COPD symptoms and quality of life in a pooled analysis of the ENHANCE trials - report from CHEST 2025

27 Nov 2025

Contributed by Lukas

Professor Nicola Hanania discuss the lessons from the ENHANCE trials were presented at the American College of Chest Physicians (CHEST) 2025 Annual Me...

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025

27 Nov 2025

Contributed by Lukas

Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than tho...

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Paola Patrignani shares her insights on the advances in the development of therapeutic targets in the platelet for prevention of thrombosis ...

Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Dr. Evan A Stein shares his insights on the emerging opportunities for managing cardiometabolic syndrome at AHA Scientific Sessions 2025.Video: https:...

2025 AHA Blood Pressure Guideline & CKD Management: Key Insights and Global Perspectives - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Eugene Yang shares his insights on the 2025 AHA Blood Pressure Guideline & CKD Management at AHA Scientific Sessions 2025.Video: https:/...

Lipid Lowering Therapies and Lipid Risk Factors - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Samia Mora explains her opinion on lipid lowering therapies and lipid risk factors at AHA Scientific Sessions 2025.Video: https://medicaldig...

The New 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Debabrata Mukherjee shares his insights on the Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025.Video: https://medical...

Aortic Regurgitation: The New Frontier - Imaging, Interventions, and the Future of Treatment - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Robert O. Bonow shares his insights on aortic regurgitation, imaging, interventions, and the future of treatment at AHA Scientific Sessions ...

Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Cécile Badoual shares her thoughts on the immuno-oncology biomarkers in locally advanced HNSCC and explains the lessons from the KeyNote-68...

Novelties of the treatment of colon cancer at ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Julien Taieb shares his thoughts on the novelties of the treatment of colon cancer at the ESMO Congress 2025.Video: https://medicaldigest.or...

How to PROC - Breaking the Wall of Platinum-Resistance in Ovarian Cancer - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Jalid Sehouli explains how to break the wall of platinum-resistance in ovarian cancer at the ESMO Congress 2025.Video: https://medicaldigest...

IMvigor011: A Phase 3 Trial of ctDNA-Guided Adjuvant Atezolizumab versus Placebo in MIBC - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Thomas B. Powles discuss the results from IMvigor011, a phase 3 trial of ctDNA-guided adjuvant atezolizumab versus placebo in muscle invasiv...

T-DXd Effective for Treating HER2+ Advanced or Metastatic Breast Cancer, Regardless of Treatment History, HR Status, or PIK3C Mutations - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Sibylle Loibl shares her thoughts on the additional analyses of DESTINY-Breast09 were presented at the ESMO Congress 2025. Key subgroup anal...

What's new in ESMO guidelines? - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Emanuela Romano explains what's new in ESMO guidelines on hepatocellular carcinoma, cutaneous melanoma, Hodgkin Lymphomas and early stag...

DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Jeanne Tie shares her thoughts on the DYNAMIC-III trial results were presented at the ESMO Congress 2025.Video: https://medicaldigest.org/sc...

Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Dirk Schadendorf shares his thoughts on the overcoming therapeutic challenges in high-risk cutaneous squamous cell carcinoma at the ESMO Con...

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Christof Vulsteke shares her thoughts on the data from the phase 3 KEYNOTE-905 trial were presented at the ESMO Congress 2025. A treatment r...

Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Maria De Santis shares her thoughts on the final analysis of the phase 3, open-Label, randomized POTOMAC trial were presented at the ESMO Co...

Treatment Landscape in Resectable LA HNSCC - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Hisham M. Mehanna shares his thoughts on the treatment landscape in resectable LA HNSCC at ESMO 2005 at the ESMO Congress 2025.Video: https:...

Analysis of Second Primary Cutaneous Squamous Cell Carcinoma Tumors Reported During the C-POST Trial - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Danny Rischin shares his thoughts on the analysis of second primary cutaneous squamous cell carcinoma tumors reported during the C-POST tria...

Unlocking the potential of radioligand therapy for advanced prostate cancer - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Irene Burger explains how to unlock the potential of radioligand therapy for advanced prostate cancer at the ESMO Congress 2025.Video: https...

Thoracic oncology - Lung cancer screening updates: switch gears to move forward - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Andriani Charpidou co-chaired a very interesting session at this year's ERS congress on lung cancer screening updates.Video: https://medical...

Advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Job F.M. van Boven co-chaired a very interesting session at this year's ERS congress on advancing lung cancer care with real-world evidence,...

Horizon scanning in the treatment of interstitial lung diseases- report from ERS 2025

13 Oct 2025

Contributed by Lukas

Dr. Nazia Chaudhuri co-chaired a very interesting session at this year's ERS congress on horizon scanning in the treatment of interstitial lung di...

Addressing the generational challenge in lung health amidst the growing number of novel tobacco products - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Andrew Bush share his thoughts on the generational challenge in lung health amidst the growing number of novel tobacco products at ERS Congress ...

The emerging therapeutic interventions for the management of interstitial lung diseases - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Michael Kreuter co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic interventions for the manageme...

Current controversies in interstitial lung diseases - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Catharina Moor co-chaired a very interesting session at this year's ERS congress on the current controversies in interstitial lung diseases....

Prevention in action: prevention in the joint action on respiratory disease - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Ildiko Horvath share her thoughts on prevention in the joint action on respiratory disease at ERS Congress 2025.Video: https://medicaldigest.org...

Understanding aging mechanisms and their effect in asthma - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Dr. Stefania Principe share her thoughts on the understanding aging mechanisms and their effect in asthma at ERS Congress 2025Video: https://medicaldi...

Lung cancer and severe respiratory comorbidities: navigating complex clinical challenges - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Mohammed Munavvar co-chaired a very interesting session at this year's ERS congress on lung cancer and severe respiratory comorbidities, how...

Benefits of twice daily inhaler dosage in the treatment of COPD - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Claus Vogelmeier share his thoughts on the benefits of twice daily inhaler dosage in the treatment of COPD at ERS Congress 2025.Video: https://m...

Real-life effectiveness of aclidinium/formoterol in COPD control: preliminary results of the REDACT observational study - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Konstantinos Kostikas share his thoughts on the real-life effectiveness of aclidinium/formoterol in COPD control at ERS Congress 2025.Video: htt...

Severe asthma: from the underlying mechanism to clinical remission - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Fabio Ricciardolo co-chaired a very interesting session at this year's ERS congress on severe asthma, from the underlying mechanism to clini...

Unlocking new pathways: emerging therapeutic targets in asthma and COPD - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Ian M. Adcock co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic targets in asthma and COPD.Video...

Epidemiology of asthma, including severe asthma - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Joan B. Soriano co-chaired a very interesting session at this year's ERS congress on the epidemiology of asthma, including severe asthma.Vid...

Unmasking COPD: Recognizing Early Signs and Tailoring Treatment - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Professor Federico Lavorini share his thoughts on the power of personalized inhalers at this year's ERS congress.Video: https://medicaldigest.org/...

Novelties in hypertension at ESC 2025

11 Sep 2025

Contributed by Lukas

Professor Anna Dominiczak co-chaired the Late-Breaking Clinical Trials Session on Hypertension at the ESC 2025 annual congress where the presentations...

Evolution of anticoagulation therapy in patients with atrial fibrillation - report from ESC 2025

11 Sep 2025

Contributed by Lukas

Professor Robert Giugliano shared his insights on the evolution of anticoagulation therapy in patients with atrial fibrillation after ESC 2025 Congres...

Cardiac myosin inhibitors in the daily practice - report from ESC 2025

10 Sep 2025

Contributed by Lukas

Professor Milind Desai shared his insights on cardiac myosin inhibitors for management of obstructive hypertrophic cardiomyopathy beyond the clinical ...

Kidney function and coronary artery disease - lessons from the EUROASPIRE IV and V studies

10 Sep 2025

Contributed by Lukas

Professor Lars Ryden shared his insights from the EUROASPIRE IV and V studies on kidney function and coronary artery disease after ESC 2025 Congress.V...

2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy

09 Sep 2025

Contributed by Lukas

Professor Julie De Backer co-chaired the 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy at ESC 2025 Congress.Video: ht...

New insights in the management of hypertrophic cardiomyopathy: exploring the clinical spectrum - report from ESC 2025

09 Sep 2025

Contributed by Lukas

Professor Iacopo Olivotto shared the new insights in the management of hypertrophic cardiomyopathy at ESC 2025 Congress.Video: https://medicaldigest.o...

2025 ESC Consensus Statement on Mental Health and Cardiovascular Disease

09 Sep 2025

Contributed by Lukas

Professor Christi Deaton co-chaired the 2025 ESC consensus statement on mental health and cardiovascular disease at ESC 2025 Congress.Video: https://m...

The importance of influenza vaccination in older people - report from ESC 2025

08 Sep 2025

Contributed by Lukas

Professor Massimo Volpe chaired an interesting session on the importance of influenza vaccination in older people at ESC 2025 Congress.Video: https://...

2025 ESC Guidelines for the Management of Myocarditis and Pericarditis

08 Sep 2025

Contributed by Lukas

Professor Jeanette Schulz-Menger co-chaired the 2025 ESC Guidelines for the management of myocarditis and pericarditis at ESC 2025 Congress.Video: htt...

2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

08 Sep 2025

Contributed by Lukas

Professor Fabien Praz co-chaired the 2025 ESC/EACTS guidelines for the management of valvular heart disease at ESC 2025 Congress.Vidoe: https://medica...

2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

08 Sep 2025

Contributed by Lukas

Professor Francois Mach co-chaired the 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias at ESC 2025 Congress.Vi...

The importance of early detection and diagnosis of dementia

28 Aug 2025

Contributed by Lukas

We asked Professor Rebecca Edelmayer, Vice President of Scientific Engagement at the Alzheimer's Association about important news about the diag...

Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations

01 Aug 2025

Contributed by Lukas

Professor Frauke Förger shares his insights on antirheumatic drugs in reproduction, pregnancy, and lactation. Gave a systematic literature review inf...

What is New in systemic lupus erythematosus?

14 Jul 2025

Contributed by Lukas

Professor Antonis Fanouriakis shares his insights on what is new in systemic lupus erythematosus at EULAR 2024.Video: https://medicaldigest.org/scient...

How to treat elevated TG in other high risk patients - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Thomas Stulnig shares his insights on how to treat elevated TG in other high risk patients at the 4th World Congress of Lipidology in Vienna...

The lower the better: never mind future drugs, use what you have available to fullest extent and lower cardiovascular risk aggressively - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Peter Toth shares his insights on how to lower cardiovascular risk at the 4th World Congress of Lipidology in Vienna, Austria.Video: https:/...

How to treat elevated Lp(a) - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Karam Kostner shares his insights how to treat elevated Lp(a) at the 4th World Congress of Lipidology in Vienna, Austria?Video: https://medi...